May 29, 2019 - Teva (TEVA) plummets after settlement with the state of Oklahoma in a litigation related to its role in opioid epidemic, resulting in a rating downgrade.
May 28, 2019 - And the analyst really likes one in particular.
May 27, 2019 - These companies are not only prominent, but they're also putting a little more money directly into the hands of their stockholders.
May 24, 2019 - The index suffered a difficult week as investors braced for a protracted U.S.-China trade war.
May 21, 2019 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix
May 20, 2019 - Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs
May 20, 2019 - AbbVie's (ABBV) phase III study on Depatux-M, an investigational candidate for newly diagnosed glioblastoma, fails to show survival benefit in patients receiving Depatux-M.
May 17, 2019 - FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs
May 16, 2019 - Geron hints at a way forward for imetelstat in myelofibrosis, but the market isn't buying it.
May 03, 2019 - Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.